1 S pinal dural arteriovenous fistulas are the most common vascular malformation of the spinal cord and its surrounding dura mater.
ed to undergo surgery unless contraindicated by medical comorbidities. Also selected to undergo surgery were asymptomatic or minimally symptomatic patients with MRI evidence of progressive T2 signal abnormality in the spinal cord or a progressive increase in the prominence of intradural flow voids.
Surgical Technique
All patients in the series underwent preoperative DSA. In the operating room, the level of the fistula was localized with cross-table C-arm fluoroscopy, and standard 1-to 2-level laminectomies were performed without significant disruption of the facet joints. Because access to the fistula can be typically achieved via a relatively narrow laminectomy, special care was taken to not destabilize the bony elements. The dura was opened to create a working intradural surgical window. The fistula was identified, typically by tracing a dorsal arterialized vein into a nerve root sleeve, and the fistula was then obliterated at the artery-vein connection either by coagulation and ligation or by using an aneurysm clip. Under direct microscopic vision, indocyanine green dye was administered to ensure disconnection of the fistula. The wound was closed in a standard fashion. Patients subsequently underwent formal digital subtraction angiography either the same day or the day after surgery.
Results
Background characteristics of 15 patients with Type I SDAVFs are provided in Table 3 . Patients' mean age was 60 years (range 40-71 years); 11 patients were male (male/female ratio 2.8:1). Presentation included weakness in 87% of the patients, numbness in 80%, paresthesias in 60%, and bowel/bladder symptoms in 47%. At least 27% of the patients had a history of neck or back trauma and 20% had undergone prior spinal decompressive surgery for spondylotic disease. In all cases, spinal decompression was performed remote to the fistula site for presumed symptomatic lumbar stenosis, without alleviation of symptoms. Notably, MRI revealed that all but 1 patient (Tables 3  and 4 ). In 1 of these patients (see Illustrative Case), endovascular therapy had failed prior to surgery. Of the 4 remaining patients, 3 were treated at another center and 1 was treated with embolization. Baseline characteristics of the patients who underwent surgery at our center were similar to those of the entire cohort. Preoperative Aminoff-Logue scores were as follows: a score of 0 was documented in 1 case (9%), a score of 1 in 1 case (9%), a score of 2 in 0 cases, a score of 3 in 7 cases (64%), a score of 4 in 2 cases (18%), and a score of 5 in 0 cases. The anatomical location of the fistulas within the spine for the surgically treated patients were: cervical in 1 patient (9%), thoracic in 6 (55%), lumbar in 3 (27%), and sacral in 1 (9%). The clinical results after surgery, with a mean follow-up duration of 4.7 months (range 1-15 months), are detailed in Table 4 . Symptoms improved in 10 (91%) of 11 patients, stayed the same in 1 (9%), and worsened in 0 patients. Specifically, 8 (73%) of 11 patients experienced improvement in strength and sensation, 5 (71%) of 7 patients had improved bowel/bladder function, 3 (60%) of 5 patients had improvement of preoperative paresthesias, and no patients suffered any other long-term neurological deficits. There was improvement in Aminoff-Logue scores in 5 patients (45%), whereas in 6 motor function was stable. Two patients suffered transient neurological worsening after surgery. One had a postoperative epidural hematoma, which was promptly evacuated, without long-term sequelae. The second patient suffered global but transient neurological decline in the setting of unrelated sepsis 4 months after surgery. There were no wound infections, CSF leaks, or permanent neurological deficits.
Illustrative Case
This 50-year-old man with a history of mild chronic neck pain was involved in a motor vehicle accident, after which his neck pain became progressively worse. Examination revealed no motor deficits or evidence of myelopathy. The T2-weighted MRI revealed cervical flow voids without cord signal change (Fig. 1A) . Subsequent angiography demonstrated a Type I SDAVF, and, at another institution, the patient underwent embolization with Onyx (ev3, Inc.). Although initial postembolization MRI showed resolution of his of intradural flow voids (Fig. 1B) , his symptoms thereafter progressed, and subsequent MRI revealed more prominent intradural flow voids (Fig. 1C) . At that time DSA demonstrated persistence of the fistula, fed by the right costocervical trunk, with new feeders inferior to the Onyx cast at the C-7 level (Fig. 1D) . This was not unexpected, as the Onyx cast did not penetrate to the fistula point.
We elected to undertake microsurgical obliteration to allow for direct access to the fistula. The patient underwent C7-T1 laminectomies, and embolic material was visible through the dural surface at the right lateral margin of the bony opening (Fig. 1E) . A durotomy was made, and a large arterialized vein was visible on the dorsal surface of the spinal cord. The fistula was isolated (Fig. 1F) , coagulated, and ligated (Fig. 1G) . Indocyanine green dye angiography performed intraoperatively demonstrated obliteration of the lesion. This was confirmed by formal postoperative DSA (Fig. 1H ), and the patient had an uncomplicated recovery with improvement in his pain and no new motor deficits.
Discussion
Early observarions of spinal vascular malformations date back to the late 19th century, as reported by Hebold and Gaupp in 1880s. 2 In the mid-20th century, WyburnMason 37 reported clinical features in a series of patients with spinal vascular fistulas. Before the advent of angiography, many authors reported spinal vascular malformations in patients with subacute myelopathy in whom they performed exploratory laminectomies or autopsies. 20 
Aminoff and Logue
2 are credited with the first largescale clinical series of patients with what are now widely known as SDAVFs. Their clinical data on 60 patients were correlated mainly with myelography. This sentinel study revealed many of the key diagnostic characteristics of SDAVFs, such as the lesion's prevalence in middleaged males, thoracolumbar predominance, gradual and progressive onset of symptoms, and nearly uniform occurrence of lower-extremity weakness and sensory dis- turbance, as well as bladder dysfunction. A follow-up study by these authors better described the natural history of SDAVFs, and they established a now widely used scale for the disability caused by this disease (Table 2) . 3 In this report, Aminoff and Logue 3 recognized the progressive and devastating nature of SDAVFs and commented that "these observations make it difficult to adopt any suggestion of therapeutic complacency in the management of patients with spinal vascular malformations." The authors further hypothesized about the pathophysiological etiology of symptoms that had been previously referable to hemorrhage or thrombosis. They proposed instead that the abnormal "shunt" led to venous congestion in the spinal plexus and resulted in a decreased arteriovenous gradient and reduced intramedullary blood flow.
1 This concept was soon updated with a correlation that supported the idea that venous congestion itself was the inciting etiology.
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The advent of angiography in the 1960s revolutionized the diagnosis and understanding of these vascular lesions.
5,11,17 Just 3 years after the landmark papers of Aminoff and Logue, 2,3 Kendall and Logue 18 published the first major clinical series with angiographic confirmation of dural-based spinal vascular malformations. This study localized SDAVFs to the dural sleeve of the nerve root and showed drainage into the coronal venous plexus of the spinal cord. Furthermore, the authors proposed a reason as to why previous authors had not localized SDAVFs to this region, namely that intradural explorations revealed only the engorged, arterialized draining veins, which were mistaken for feeding arteries. This discovery led to further refinement of the anatomy of Type I SDAVFs, specifically that they are fed by a radicular artery and drain into a medullary vein, filling the coronal venous plexus retrograde.
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Many classifications schemas have been proposed for spinal vascular malformations 6, 7, 10, 13, 19, 21 (Table 1) . Type I fistulas, as discussed in this report, are fed by radicular arteries and are low-pressure and low-flow vascular shunts. They are located within the dural sleeve of a nerve root and rarely present with hemorrhage but more commonly with myelopathy. Type II fistulas are located within the spinal cord itself and are true pial AVMs. 8, 9 They are high-pressure and high-flow shunts that are typically supplied by feeders off the ASA, PSA, or the vertebral artery. These fistulas can present with myelopathy or hemorrhage. Type III SDAVFs are also high-flow shunts, derived from any feeding arteries, but extend both intraand extradurally.
25 They are extremely rare but also difficult to treat because of their size.
12,23 Type IV SDAVFs are perimedullary fistulas, with variable flow and pressure, that can present with myelopathy or hemorrhage. 15 The identifying characteristic of the Type IV fistula is that it is fed directly from the ASA or PSA, also making safe treatment difficult. 4 
Saladino and colleagues
30 reported the largest singlecenter surgical series of patients with Type I SDAVF. Their series of 154 patients treated with microsurgical obliteration of SDAVFs had similar baseline characteristics as the individuals in our study: a mean age of 63.6 years, 3.5:1 male/female ratio, and predilection of the lesions for a thoracic location. Of the 141 patients with available follow-up data, 82.2% had improvement in motor function and 14.4% had stability in motor function. No patients suffered major neurological complications.
Tacconi and coworkers 34 reported on a surgical cohort of 78 patients, focusing on 25 with long-term followup. Patients' postoperative neurological status was most closely dependent on their preoperative function. This observation underscores the need to treat patients with newly discovered SDAVFs in an expedient fashion, as the natural history of the disease is of progressive myelopathy and not spontaneous regression and resolution. Another interesting finding was that patients in whom the fistulas were clipped and excised had statistically better outcomes than those in whom only a clip was placed.
In our series, all patients had favorable outcomeseither long-term improvement or stability of preoperative symptoms. Although endovascular therapies can be limited by recanalization, as illustrated in the Illustrative Case, or inability to successfully embolize anatomically complex fistulas, this modality offers a less-invasive approach to treatment. Early reports of endovascular management with polyvinyl alcohol demonstrated high recanalization rates.
14 Recently, liquid embolic agents have become the substance of choice for endovascular surgeons, and early experience has shown improved initial success rates (range 75%-80%) over previous materials. 27, 32 In 1 single-institutional series with approximately 3 years of follow-up, of 39 patients undergoing embolization, 27 (69%) had complete obliteration of the lesion. 26 Specifically, in those treated with liquid embolic agents, an additional procedure was necessary in 25% of cases. In an early meta-analysis by Steinmetz et al., 33 there was a 98% initial success rate for microsurgical obliteration of Type I SDAVFs compared with 46% for endovascular therapy. However, as endovascular techniques continue to evolve, a recent pooled literature review examining endovascular obliteration with liquid embolic agents reported a success rate between 70% and 90%.
31 Nevertheless, many of these studies are limited by short follow-up periods relative to the larger microsurgical series. Endovascular approaches may not be able to reach the fistula point and deliver embolic material to the proximal draining vein, preventing direct embolization and relying instead on the permeability of the embolization agent to reach it. When this does not occur, initial palliation of symptoms and radiologically demonstrated improvement may occur, although recruitment of other arterial feeders and/or recanalization often occurs. Furthermore, endovascular therapy may be contraindicated if the radicular artery is in fact a radiculomedullary artery supplying the ASA. 29 In contrast, microsurgery allows for direct visualization of the fistula point and safe ligation without reliance on the morphology of access vessels and their contributions to the ASA.
Although limited by its small sample size, this study contributes to the literature, demonstrating the efficacy, feasibility, and safety of microsurgical treatment of Type I SDAVFs. All fistulas were successfully angiographically obliterated with either improvement or stability of symptoms. There were no permanent untoward events, and there were no cases of spinal instability requiring immediate or delayed instrumentation, which is a belief still held by some surgeons.
Conclusions
Patients with Type I SDAVFs warrant prompt treatment due to the progressive nature of their disease. Providing direct access to the fistula point, microsurgical treatment can be performed with exceedingly high obliteration rates and long-term postoperative improvement of preexisting deficits in the majority of cases. In our experience, all fistulas were obliterated, with 73% of patients experiencing improvement of preoperative motor and/or sensory deficits, 71% having improvement of preoperative bowel/bladder symptoms, and 60% having improvement of preoperative paresthesias.
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